Hypertension. 2005;46:1243-1249
Published online before print October 17, 2005, doi: 10.1161/01.HYP.0000188408.49896.c5
Published online before print October 17, 2005, doi: 10.1161/01.HYP.0000188408.49896.c5
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2005;46:1243.)
© 2005 American Heart Association, Inc.
Brief Reviews |
Preeclampsia
Recent Insights
From the Magee-Womens Research Institute (J.M.R.) and the Departments of Obstetrics, Gynecology, and Reproductive Sciences (J.M.R., H.S.G.), and Epidemiology (J.M.R.) University of Pittsburgh, Pennsylvania.
Correspondence to James M. Roberts, MD, Magee-Womens Research Institute, 204 Craft Ave, Pittsburgh, PA 15213. E-mail RSIJMR{at}mwri.magee.edu
Preeclampsia is a pregnancy complication with serious consequences for mother and infant. The disorder is diagnosed by gestational hypertension and proteinuria but is far more than pregnancy induced hypertension. Preeclampsia is proposed to occur in 2 stages. Stage 1 reduced placental perfusion is postulated as the root cause and to lead to the maternal syndrome, Stage 2. Why perfusion is reduced, how this translates to a maternal disease in some but not all women and what is the linkage of the 2 stages are topics of intense study. In the last decade such studies have provided valuable insights into pathophysiology that now guide ongoing clinical trials.
Key Words: preeclampsia • hypertension, pregnancy • oxidative stress • endothelium
This article has been cited by other articles:
 |
|
 |
|
  J. M. Roberts and A. Rajakumar Preeclampsia and Soluble fms-Like Tyrosine Kinase 1 J. Clin. Endocrinol. Metab., July 1, 2009; 94(7): 2252 - 2254. [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. Gombos, V. Wolan, K. McDonald, and D. G. Hemmings Impaired vascular function in mice with an active cytomegalovirus infection Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H937 - H945. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Fitzpatrick, M.P. Johnson, T.D. Dyer, S. Forrest, K. Elliott, J. Blangero, S.P. Brennecke, and E.K. Moses Genetic association of the activin A receptor gene (ACVR2A) and pre-eclampsia Mol. Hum. Reprod., March 1, 2009; 15(3): 195 - 204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Strek Critical Illness in Pregnancy ACCP Crit Care Med Brd Rev, January 1, 2009; 20(0): 179 - 196. [Full Text] [PDF]
|
|
|
|
 |
|
 W. Chen and R. A. Khalil Differential [Ca2+]i signaling of vasoconstriction in mesenteric microvessels of normal and reduced uterine perfusion pregnant rats Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R1962 - R1972. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Wu, Y. Sun, M. Vestergaard, J. Christensen, R. B. Ness, C. L. Haggerty, and J. Olsen Preeclampsia and Risk for Epilepsy in Offspring Pediatrics, November 1, 2008; 122(5): 1072 - 1078. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Munaut, S. Lorquet, C. Pequeux, S. Blacher, S. Berndt, F. Frankenne, and J.-M. Foidart Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast Hum. Reprod., June 1, 2008; 23(6): 1407 - 1415. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Williams, C. Ojaimi, K. Qanud, S. Zhang, X. Xu, F. A. Recchia, and T. H. Hintze Coronary nitric oxide production controls cardiac substrate metabolism during pregnancy in the dog Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2516 - H2523. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. C Chappell and A. H Shennan Assessment of proteinuria in pregnancy BMJ, May 3, 2008; 336(7651): 968 - 969. [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Roberts and J. M. Catov Preeclampsia More Than 1 Disease: Or Is It? Hypertension, April 1, 2008; 51(4): 989 - 990. [Full Text] [PDF]
|
|
|
|
|
|
B. D. LaMarca, J. Gilbert, and J. P. Granger Recent Progress Toward the Understanding of the Pathophysiology of Hypertension During Preeclampsia Hypertension, April 1, 2008; 51(4): 982 - 988. [Full Text] [PDF]
|
|
|
|
|
|
S. Rasmussen and L. M. Irgens History of Fetal Growth Restriction Is More Strongly Associated With Severe Rather Than Milder Pregnancy-Induced Hypertension Hypertension, April 1, 2008; 51(4): 1231 - 1238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Luksha, H. Nisell, N. Luksha, M. Kublickas, K. Hultenby, and K. Kublickiene Endothelium-derived hyperpolarizing factor in preeclampsia: heterogeneous contribution, mechanisms, and morphological prerequisites Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2008; 294(2): R510 - R519. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Li, Y. Zhang, J. Ying Ma, A. M. Kapoun, Q. Shao, I. Kerr, A. Lam, G. O'Young, F. Sannajust, P. Stathis, et al. Recombinant Vascular Endothelial Growth Factor 121 Attenuates Hypertension and Improves Kidney Damage in a Rat Model of Preeclampsia Hypertension, October 1, 2007; 50(4): 686 - 692. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Troisi, N. Potischman, and R. N. Hoover Exploring the Underlying Hormonal Mechanisms of Prenatal Risk Factors for Breast Cancer: A Review and Commentary Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1700 - 1712. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. V. Ilekis, U. M. Reddy, and J. M. Roberts Review Article: Preeclampsia A Pressing Problem: An Executive Summary of a National Institute of Child Health and Human Development Workshop Reproductive Sciences, September 1, 2007; 14(6): 508 - 523. [Abstract] [PDF]
|
|
|
|
|
|
L. M. Bodnar, J. M. Catov, H. N. Simhan, M. F. Holick, R. W. Powers, and J. M. Roberts Maternal Vitamin D Deficiency Increases the Risk of Preeclampsia J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3517 - 3522. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Tsukimori, H. Nakano, and N. Wake Difference in Neutrophil Superoxide Generation During Pregnancy Between Preeclampsia and Essential Hypertension Hypertension, June 1, 2007; 49(6): 1436 - 1441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Rasmussen and L. M. Irgens Pregnancy-Induced Hypertension in Women Who Were Born Small Hypertension, April 1, 2007; 49(4): 806 - 812. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. T. Alexander Prenatal Influences and Endothelial Dysfunction: A Link Between Reduced Placental Perfusion and Preeclampsia Hypertension, April 1, 2007; 49(4): 775 - 776. [Full Text] [PDF]
|
|
|
|
|
|
J. M. Roberts and F. Von Versen-Hoeynck Maternal Fetal/Placental Interactions and Abnormal Pregnancy Outcomes Hypertension, January 1, 2007; 49(1): 15 - 16. [Full Text] [PDF]
|
|